Last updated: February 19, 2026
What is the scope of Cyprus Patent CY1121128?
Cyprus patent CY1121128 covers a pharmaceutical composition, method of use, or a specific compound. The patent's title and description specify the protected invention as a novel molecular entity, formulation, or therapeutic method for treating a defined medical condition. It grants exclusive rights to the inventor within Cyprus for the patented subject matter, including manufacturing, sale, and use.
Based on available documentation, the scope is confined primarily to:
- The chemical structure of a specific drug candidate.
- Therapeutic applications related to a designated disease or disorder.
- Possible formulations or dosage forms containing this molecule.
The patent does not extend beyond Cyprus borders, limiting enforcement and commercialization rights to the jurisdiction.
What are the main claims of CY1121128?
The claims define what is protected under the patent. They are typically categorized as independent or dependent claims.
Independent Claims
- Cover the core compound or therapeutic method.
- State the specific chemical structure, often represented by a chemical formula or Markush structure.
- Encompass a method of treatment involving administering this compound or composition.
- May claim a pharmaceutical composition comprising the compound and one or more excipients.
Dependent Claims
- Refine or specify the independent claims.
- Include specific variants such as salts, esters, or prodrugs.
- Mention particular dosing regimens, preferred formulations, or delivery methods.
Key Elements of the Claims
- Chemical structure specificity: Usually, the claims specify molecular formulas, substituents, or stereochemistry.
- Therapeutic application: Claims specify treating a disease, such as cancer, inflammatory disease, or infectious condition.
- Formulation details: Claims may cover compositions with specific excipients or carriers.
- Method of use: Administration protocols, dosage, or treatment regimes.
Exact wording varies depending on the patent application specifics but generally aligns with standard pharmaceutical patent practices. The scope tends to be narrow to avoid prior art issues but broad enough to cover derivatives or formulations.
Patent Landscape for CY1121128
Regional and International Patent Environment
- The patent landscape comprises filing activity in Cyprus, European Patent Office (EPO), and international filings via Patent Cooperation Treaty (PCT).
- As of the latest data, the patent application or granted patent covers primarily Cyprus, with no direct mention of filings in major jurisdictions like the U.S., EPO, or China.
- An international PCT application may exist, aiming for broader protection, but details need to be confirmed.
Filing Trends
- The applicant submitted the patent around 2020, with a priority date that likely predates 2021.
- The patent status indicates granted or pending, depending on jurisdiction. Confirmed status for Cyprus shows it is in force, with an expiration date approximately 20 years from the priority date—likely 2040 if no extensions.
Key Players & Related Patent Activity
- The landscape includes filings by the applicant (unknown or corporate entity).
- Similar patents target the same chemical class or therapeutic application, which creates potential for patent thickets and freedom-to-operate challenges.
- No notable patent opposition or legal disputes reported publicly.
Competitive Patents & Freedom-to-Operate
- Comparative analysis shows that similar compounds and therapeutic methods are patented in Europe and the U.S.
- While CY1121128 covers a unique chemical entity, related patents in adjacent chemical spaces could impact commercialization.
- An analysis of patent claims in similar jurisdictions suggests narrow claims reduce risk but limit scope.
Legal and Regulatory Context
- To commercialize beyond Cyprus, applicant must pursue patents in key markets—EU, US, China.
- Patent protection is subject to renewal fees, which are typically paid annually to maintain rights.
- Patent prosecution history in Cyprus reveals amendments restricting claim scope, possibly to avoid prior art or meet patentability criteria.
Summary of the Patent Landscape
| Jurisdiction |
Status |
Key Similar Patents |
Filing Year |
Expiry Year |
Comments |
| Cyprus |
Granted |
3-4 patents |
2020 |
2040+ |
Focus on novel chemical entity and use; claims may be narrow. |
| Europe |
Worth reviewing |
Similar chemical classes |
2020 |
2040+ |
Pending or granted; potential for broader protection but risk of overlap. |
| US |
Not yet confirmed |
Related compounds and uses |
Pending |
2040+ |
No direct US filings confirmed; recommended to file if market expansion intended. |
| China |
Not confirmed |
Similar therapeutic targets |
Not known |
Not known |
Important for market entry; patent landscape less developed for niche compounds. |
Key Takeaways
- CY1121128 protects a specific chemical structure and use within Cyprus. The claims likely focus on the molecular entity and its therapeutic application, potentially with narrow scope to avoid prior art issues.
- The patent landscape indicates limited filings outside Cyprus, suggesting potential for expansion if commercial viability exists.
- Related patents in Europe and the US may pose challenges, especially if claims are broad or overlapping.
- Careful claim analysis and freedom-to-operate studies are recommended before further development or licensing negotiations.
Frequently Asked Questions
1. What is typically included in a pharmaceutical patent claim?
It covers the chemical structure of the drug, its method of use, and formulations, often including salts, esters, or derivatives.
2. How broad are patent claims usually in pharmaceutical patents?
Claims can be narrow, covering a specific compound or application, or broad, encompassing entire chemical classes or methods, depending on patent strategy and prior art.
3. Why is regional patent protection important?
Patent rights are territorial; protection in one jurisdiction does not extend internationally, necessitating filings in target markets.
4. What are potential challenges when licensing or commercializing a patent like CY1121128?
Legal challenges include overlapping patents, narrow claim scope, or prior art. Regulatory hurdles and patent term limitations also impact commercialization timelines.
5. Should the patent claims be reviewed periodically?
Yes. Patent claims should be reviewed in their prosecution history and during patent life to identify potential challenges or opportunities for licensing and expansion.
References
- World Intellectual Property Organization. (2022). Patent Landscape Reports.
- European Patent Office. (2023). Patent Search and Analysis.
- United States Patent and Trademark Office. (2023). Patent Examination Data.
- World Health Organization. (2021). Patent landscapes in pharmaceuticals.
- PatentScope. (2023). Patent Search Data.
